Evidence map›Paper›PMID 31991717›Full record

ArticleInternational journal of molecular sciences2020

Modulation of Pro-Oxidant and Pro-Inflammatory Activities of M1 Macrophages by the Natural Dipeptide Carnosine.

Claudia G Fresta, Annamaria Fidilio, Giacomo Lazzarino, Nicolò Musso, Margherita Grasso, Sara Merlo, Angela M Amorini, Claudio Bucolo, Barbara Tavazzi, Giuseppe Lazzarino and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Histidine-Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Claudia G FrestaRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS 66047-1620, USA.
Annamaria FidilioDepartment of Drug Sciences, University of Catania, 95125 Catania, Italy.
Giacomo LazzarinoUniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Nicolò MussoBio-nanotech Research and Innovation Tower (BRIT), University of Catania, 95125 Catania, Italy.
Margherita GrassoDepartment of Drug Sciences, University of Catania, 95125 Catania, Italy.
Sara MerloDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Angela M AmoriniDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Claudio BucoloDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Barbara TavazziInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, 00168 Rome, Italy.
Giuseppe LazzarinoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Susan M LunteRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS 66047-1620, USA.
Filippo CaraciDepartment of Drug Sciences, University of Catania, 95125 Catania, Italy.
Giuseppe CarusoOasi Research Institute-IRCCS, 94018 Troina (EN), Italy.
University of Catania · ITUniversity of Kansas · USOasi Maria SS · ITUniversità Cattolica del Sacro Cuore · IT

Funding

American Heart Association NFP0075515Italian Ministry of Health Research Program 2018 RC: 2635256
6 · The paper itself

Abstract

Carnosine is a natural endogenous dipeptide widely distributed in mammalian tissues, existing at particularly high concentrations in the muscles and brain and possesses well-characterized antioxidant and anti-inflammatory activities. In an in vitro model of macrophage activation, induced by lipopolysaccharide + interferon-gamma (LPS + IFN-γ), we here report the ability of carnosine to modulate pro-oxidant and pro-inflammatory activities of macrophages, representing the primary cell type that is activated as a part of the immune response. An ample set of parameters aimed to evaluate cytotoxicity (MTT assay), energy metabolism (HPLC), gene expressions (high-throughput real-time PCR (qRT-PCR)), protein expressions (western blot) and nitric oxide production (qRT-PCR and HPLC), was used to assess the effects of carnosine on activated macrophages challenged with a non cytotoxic LPS (100 ng/mL) + IFN-γ (600 U/mL) concentration. In our experimental model, main carnosine beneficial effects were: (1) the modulation of nitric oxide production and metabolism; (2) the amelioration of the macrophage energy state; (3) the decrease of the expressions of pro-oxidant enzymes (Nox-2, Cox-2) and of the lipid peroxidation product malondialdehyde; (4) the restoration and/or increase of the expressions of antioxidant enzymes (Gpx1, SOD-2 and Cat); (5) the increase of the transforming growth factor-β1 (TGF-β1) and the down-regulation of the expressions of interleukins 1β and 6 (IL-1β and IL-6) and 6) the increase of the expressions of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and heme oxygenase-1 (HO-1). According to these results carnosine is worth being tested in the treatment of diseases characterized by elevated levels of oxidative stress and inflammation (atherosclerosis, cancer, depression, metabolic syndrome, and neurodegenerative diseases).

Indexed as

AnimalsAntioxidantsCarnosineCell Line, TumorCell SurvivalCytokinesEnergy MetabolismGene Expression ProfilingImmunomodulationInflammation MediatorsLipopolysaccharidesMacrophage ActivationMacrophagesMiceNitric OxideNitric Oxide Synthase Type IIAntioxidantsCarnosineCytokinesInflammation MediatorsLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IIOxidantsantioxidantscarnosineenergy metabolisminflammationM1 macrophagesnitric oxideoxidative stress

Identifiers

PMID31991717
PMCPMC7038063
OpenAlexW3001293230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.